Get the Stockscreener App
521.11
0.19%
0.99
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $521.11, with a volume of 2.03M.
It is up +0.19% in the last 24 hours and down -16.48% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$520.12
Open:
$515.73
24h Volume:
2.03M
Relative Volume:
0.95
Market Cap:
$195.79B
Revenue:
$44.56B
Net Income/Loss:
$6.73B
P/E Ratio:
29.38
EPS:
17.7391
Net Cash Flow:
$6.29B
1W Performance:
+1.99%
1M Performance:
-16.48%
6M Performance:
+6.76%
1Y Performance:
-0.41%
1-Day Range:
$509.48
$521.28
1-Week Range:
$505.80
$521.63
52-Week Range:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
521.11 | 195.41B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
210.64 | 148.05B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
656.73 | 52.76B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
121.38 | 34.22B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.38 | 31.67B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
The immortal life of Henrietta Lacks lawsuits gets a bit shorter with Novartis settlement - Fortune
Thermo Fisher extends two leases in Middleton - The Daily Reporter
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026 - The Chronicle-Journal
TIAA Trust National Association Buys 7,064 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Xponance Inc. Sells 3,464 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Handelsbanken Fonder AB Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
PCR Technologies Market Is Going to Boom Rapidly | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd. - openPR.com
Erste Asset Management GmbH Trims Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Stock To $390? - Trefis
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT In - GuruFocus
Here's What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings - Finviz
Thermo Fisher Scientific Finalizes $3.8 Billion Senior Notes Offering - Global Legal Chronicle
Did Thermo Fisher’s (TMO) 10% Dividend Hike After Earnings Beat Just Reframe Its Capital Return Story? - simplywall.st
Thermo Fisher Scientific Inc. (NYSE:TMO) Announces Quarterly Dividend of $0.47 - MarketBeat
Westpac Banking Corp Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner - Business Wire
Precision Medicine Market 2026–2031 Growth: 13%+ CAGR as AI Integration and Biomarker Advancements Drive Adoption, Reports Mordor Intelligence - GlobeNewswire Inc.
Thermo Fisher Announces 10% Increase in Quarterly Dividend - Intellectia AI
Thermo Fisher Scientific (TMO) Boosts Dividend by 10% - GuruFocus
Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO) - Finviz
Thermo Fisher Scientific Increases Quarterly Dividend - PharmiWeb.com
Thermo Fisher Scientific (TMO) Announces Future Dividend Payment - GuruFocus
Thermo Fisher raises quarterly dividend 10% to $0.47 per share - Investing.com
Thermo Fisher raises quarterly dividend 10% to $0.47 per share By Investing.com - Investing.com South Africa
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks? - Barchart.com
Thermo Fisher Datavant Deal Deepens Real World Data Role In Trials - Yahoo Finance UK
Scientific Data Management System Market Is Going to Boom - openPR.com
Digital Cytology Market Is Going to Boom | Roche • Thermo Fisher Scientific • PerkinElmer - openPR.com
Parasitology Market Is Going to Boom | Thermo Fisher Scientific • Merck KGaA • Abbott Laboratories - openPR.com
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference - BioSpace
Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Pullback - simplywall.st
FDA Approved Thermo Fisher Scientific’s (TMO) Oncomine Dx Express Test - MSN
Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast - Finviz
Thermo Fisher’s Datavant Data Tie-Up Could Be A Game Changer For Thermo Fisher Scientific (TMO) - Yahoo Finance
How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga
Innovating Texture and Culture in Plant-Based Foods - News-Medical
Next Generation Sequencing Market Competitive Landscape - GlobeNewswire
Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top PlayersThermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance
Ion Chromatography Market Is Going to Boom |• Thermo Fisher Scientific • Agilent Technologies - openPR.com
Bioprocessing Reagents Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA - openPR.com
Thermo Fisher Scientific (TMO) Valuation Check As Datavant Data Partnership Draws Fresh Investor Interest - Yahoo Finance
Thermo Fisher boosts connected planning with Oracle Cloud EPM - Oracle
Thermo Fisher-Clario deal open for views in EU - MLex
Is It Time To Revisit Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance
Thermo Fisher Datavant Data Link Draws Focus To TMO Valuation And Risks - simplywall.st
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading - Yahoo Finance
Alliance Wealth Advisors LLC UT Has $617,000 Holdings in Thermo Fisher Scientific Inc. $TMO - Defense World
Thermo Fisher Scientific Inc. $TMO Shares Bought by Bleakley Financial Group LLC - Defense World
Tredje AP fonden Sells 32,000 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Raised by Raiffeisen Bank International AG - MarketBeat
Thermo Fisher Microscopes: The Lab Upgrade US Scientists Are Racing To Get - AD HOC NEWS
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):